Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

NVS

Novartis AG

Healthcare · USD

Set alert

Price alert · NVS

All alert types
160.79 USD -0.31 -0.19%
As of Oct 30, 2026 Extended hours 161.10 +0.19%
Bid
160.68 × 300
Ask
160.79 × 200
160.42 Day range 164.06
122.61 52-week range 168.62
YTD
+16.62%
1 year
+31.14%
Open
162.53
Prev close
161.10
Mkt cap
303.67B
Vol
3.15M
Avg vol
2.02M
EPS
5.24
P/E
30.69
Div yield
2.94%
More statistics
Low
160.42
High
164.06
Forward P/E
16.23
Beta
0.47
Short ratio
3.01
Inst. own
7.31%
Dividend
4.74
Ex-div date
Mar 10, 2026
Earnings
Feb 3, 2027
50-d avg
148.31
200-d avg
151.74
1y target
155.29

5D chart

Chart tools
Interval
1m5m15m30m
NVS five-day price chart152.0155.0158.0161.0164.1Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

3.60 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 4
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 2
  • P/B 1

Valuation

P/E 19.0×
FY 2016: 21.6×FY 2017: 21.4×FY 2018: 13.2×FY 2019: 28.7×FY 2020: 25.2×FY 2021: 7.7×FY 2022: 26.9×FY 2023: 14.1×FY 2024: 16.4×FY 2025: 19.0×
FY 2016 5y median 16.4× FY 2025
P/S 4.9×
FY 2016: 2.9×FY 2017: 3.8×FY 2018: 3.6×FY 2019: 4.2×FY 2020: 4.1×FY 2021: 4.2×FY 2022: 4.3×FY 2023: 4.5×FY 2024: 3.8×FY 2025: 4.9×
FY 2016 5y median 4.3× FY 2025
P/B 5.8×
FY 2016: 1.9×FY 2017: 2.2×FY 2018: 2.1×FY 2019: 3.7×FY 2020: 3.6×FY 2021: 2.7×FY 2022: 3.2×FY 2023: 4.5×FY 2024: 4.5×FY 2025: 5.8×
FY 2016 5y median 4.5× FY 2025
P/FCF 15.1×
FY 2016: 16.9×FY 2017: 16.7×FY 2018: 15.3×FY 2019: 18.1×FY 2020: 18.4×FY 2021: 14.8×FY 2022: 15.6×FY 2023: 17.9×FY 2024: 14.2×FY 2025: 15.1×
FY 2016 5y median 15.1× FY 2025
EV/EBITDA 12.7×
FY 2016: 11.1×FY 2017: 12.6×FY 2018: 9.2×FY 2019: 14.3×FY 2020: 13.5×FY 2021: 6.6×FY 2022: 14.1×FY 2023: 12.2×FY 2024: 10.4×FY 2025: 12.7×
FY 2016 5y median 12.2× FY 2025
EV/Sales 5.3×
FY 2016: 3.3×FY 2017: 4.2×FY 2018: 4.0×FY 2019: 4.6×FY 2020: 4.6×FY 2021: 4.6×FY 2022: 4.8×FY 2023: 4.8×FY 2024: 4.2×FY 2025: 5.3×
FY 2016 5y median 4.8× FY 2025
FCF Yield 6.6%
FY 2016: 5.9%FY 2017: 6.0%FY 2018: 6.6%FY 2019: 5.5%FY 2020: 5.4%FY 2021: 6.7%FY 2022: 6.4%FY 2023: 5.6%FY 2024: 7.0%FY 2025: 6.6%
FY 2016 5y median 6.6% FY 2025

Profitability

Gross Margin 75.0%
FY 2016: 64.6%FY 2017: 68.6%FY 2018: 68.5%FY 2019: 70.4%FY 2020: 69.7%FY 2021: 73.3%FY 2022: 73.4%FY 2023: 73.3%FY 2024: 75.2%FY 2025: 75.0%
FY 2016 5y median 73.4% FY 2025
Operating Margin 31.2%
FY 2016: 16.7%FY 2017: 20.0%FY 2018: 18.2%FY 2019: 18.7%FY 2020: 20.3%FY 2021: 22.9%FY 2022: 18.3%FY 2023: 20.9%FY 2024: 28.1%FY 2025: 31.2%
FY 2016 5y median 22.9% FY 2025
Net Margin 25.6%
FY 2016: 13.6%FY 2017: 17.7%FY 2018: 27.4%FY 2019: 24.1%FY 2020: 16.2%FY 2021: 54.6%FY 2022: 16.0%FY 2023: 31.8%FY 2024: 23.1%FY 2025: 25.6%
FY 2016 5y median 25.6% FY 2025
ROE 30.5%
FY 2016: 9.0%FY 2017: 10.4%FY 2018: 16.0%FY 2019: 21.1%FY 2020: 14.3%FY 2021: 35.5%FY 2022: 11.7%FY 2023: 31.8%FY 2024: 27.1%FY 2025: 30.5%
FY 2016 5y median 30.5% FY 2025
ROIC 15.5%
FY 2016: 6.1%FY 2017: 6.2%FY 2018: 6.1%FY 2019: 7.5%FY 2020: 7.6%FY 2021: 8.7%FY 2022: 7.1%FY 2023: 11.5%FY 2024: 15.5%FY 2025: 15.5%
FY 2016 5y median 11.5% FY 2025
ROA 12.2%
FY 2016: 5.2%FY 2017: 5.8%FY 2018: 8.7%FY 2019: 9.9%FY 2020: 6.1%FY 2021: 18.2%FY 2022: 5.9%FY 2023: 14.9%FY 2024: 11.7%FY 2025: 12.2%
FY 2016 5y median 12.2% FY 2025

Growth (YoY)

Revenue 6.0%
FY 2016: -1.9%FY 2017: -12.2%FY 2018: 6.2%FY 2019: 5.6%FY 2020: 2.5%FY 2021: -11.9%FY 2022: -1.2%FY 2023: 7.4%FY 2024: 10.8%FY 2025: 6.0%
FY 2016 FY 2025
Operating Income 17.4%
FY 2016: -7.9%FY 2017: 5.2%FY 2018: -3.4%FY 2019: 8.1%FY 2020: 11.7%FY 2021: -0.9%FY 2022: -21.0%FY 2023: 22.9%FY 2024: 48.9%FY 2025: 17.4%
FY 2016 FY 2025
EPS (diluted) 22.5%
FY 2016: -61.6%FY 2017: 16.1%FY 2018: 65.5%FY 2019: -42.8%FY 2020: 14.3%FY 2021: 202.0%FY 2022: -70.2%FY 2023: 124.0%FY 2024: -17.3%FY 2025: 22.5%
FY 2016 FY 2025
Free Cash Flow 28.1%
FY 2016: 6.8%FY 2017: 14.9%FY 2018: 10.6%FY 2019: 4.1%FY 2020: -2.7%FY 2021: 13.1%FY 2022: -4.1%FY 2023: -2.4%FY 2024: 17.9%FY 2025: 28.1%
FY 2016 FY 2025

Financial Health

Current Ratio 1.1×
FY 2016: 1.1×FY 2017: 1.2×FY 2018: 1.2×FY 2019: 1.0×FY 2020: 0.9×FY 2021: 1.5×FY 2022: 1.3×FY 2023: 1.2×FY 2024: 1.0×FY 2025: 1.1×
FY 2016 5y median 1.2× FY 2025
Quick Ratio 0.9×
FY 2016: 0.8×FY 2017: 0.9×FY 2018: 1.0×FY 2019: 0.8×FY 2020: 0.7×FY 2021: 1.3×FY 2022: 1.0×FY 2023: 0.9×FY 2024: 0.8×FY 2025: 0.9×
FY 2016 5y median 0.9× FY 2025
Debt / Equity 0.8×
FY 2016: 0.3×FY 2017: 0.4×FY 2018: 0.4×FY 2019: 0.5×FY 2020: 0.7×FY 2021: 0.5×FY 2022: 0.5×FY 2023: 0.6×FY 2024: 0.7×FY 2025: 0.8×
FY 2016 5y median 0.6× FY 2025
Net Debt / EBITDA 1.1×
FY 2016: 1.2×FY 2017: 1.3×FY 2018: 0.9×FY 2019: 1.2×FY 2020: 1.6×FY 2021: 0.6×FY 2022: 1.4×FY 2023: 0.7×FY 2024: 1.0×FY 2025: 1.1×
FY 2016 5y median 1.0× FY 2025
Interest Coverage 14.4×
FY 2016: 11.3×FY 2017: 10.9×FY 2018: 8.6×FY 2019: 10.1×FY 2020: 11.0×FY 2021: 11.1×FY 2022: 9.5×FY 2023: 11.2×FY 2024: 14.0×FY 2025: 14.4×
FY 2016 5y median 11.2× FY 2025

Dividends

Dividend Yield 2.9%
FY 2016: 4.5%FY 2017: 3.9%FY 2018: 4.2%FY 2019: 3.2%FY 2020: 3.4%FY 2021: 4.0%FY 2022: 4.0%FY 2023: 3.5%FY 2024: 3.9%FY 2025: 2.9%
FY 2016 5y median 3.9% FY 2025
Payout Ratio 55.9%
FY 2016: 96.5%FY 2017: 84.3%FY 2018: 55.2%FY 2019: 56.6%FY 2020: 86.6%FY 2021: 30.7%FY 2022: 107.9%FY 2023: 48.9%FY 2024: 63.8%FY 2025: 55.9%
FY 2016 5y median 55.9% FY 2025

Annual · latest fiscal year ends 2025-12-31